In a mouse model of breast cancer, the combination of an anti-KLRG1 antibody with a DNA methyltransferase inhibitor further reduced the metastatic potential of breast cancer and effectively prevented metastatic recurrence compared to use of the antibody alone [26]. Here, KLRG1 is linked to breast carcinoma.